|
ABSTRACT
The colon is a site where both local and
systemic delivery of drugs can take place. Local delivery allows topical
treatment of inflammatory bowel disease. However, treatment can be made
effective if the drugs can be targeted directly into the colon, thereby reducing
the systemic side effects. This review, mainly compares the primary approaches
for CDDS (Colon Specific Drug Delivery) namely prodrugs, pH and time dependent
systems, and microbially triggered systems, which achieved limited success and
had limitations as compared with newer CDDS namely pressure controlled colonic
delivery capsules, CODESTM, and osmotic controlled drug delivery which are
unique in terms of achieving in vivo site specificity, and feasibility of
manufacturing process.
|
|
|
Department of Pharmaceutics, School of Pharmacy, University of Nizwa, Birkat Al Mouz, Nizwa-616, Sultanate of Oman.
Received: 07 Feb 2010
Accepted: 14 Mar 2010
Address correspondence and reprint request to: Dr. Anil K. Philip, Assistant Professor
Department of Pharmaceutics, School of Pharmacy, College of Pharmacy and Nursing,
University of Nizwa, Birkat Al Mouz, Nizwa-616, Sultanate of Oman.
E-mail: philip@unizwa.edu.om, philipanil23@yahoo.co.in
Philip AK, et al. OMJ. 25, 70-78 (2010); doi:10.5001/omj.2010.24
|
|